Drug Profile
HIV edible vaccine - ProdiGene
Alternative Names: HIV vaccine edible - ProdiGeneLatest Information Update: 12 Jan 2004
Price :
$50
*
At a glance
- Originator ProdiGene
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 12 Jan 2004 No development reported - Preclinical for HIV-1 infections in USA (PO)
- 14 Nov 2003 This vaccine is still in active development
- 01 Dec 2000 Preclinical development for HIV-1 infections in USA (PO)